CA3051146A1 — Crystal form of gft-505 and preparation method and use thereof
Assigned to Crystal Pharmaceutical Suzhou Co Ltd · Expires 2018-07-26 · 8y expired
What this patent protects
The present invention relates to crystal forms of GFT-505 and a preparation method and use thereof. The provided crystal forms of GFT-505, CS1, CS2, CS5, and CS6, have high purities, good stabilities, low hygroscopicities, good solubilities, and high mechanical stabilities. The p…
USPTO Abstract
The present invention relates to crystal forms of GFT-505 and a preparation method and use thereof. The provided crystal forms of GFT-505, CS1, CS2, CS5, and CS6, have high purities, good stabilities, low hygroscopicities, good solubilities, and high mechanical stabilities. The present invention provides a new and better choice for the preparation of a pharmaceutical preparation comprising the GFT-505 and is of great significance for drug development.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.